Structure and specificity of nuclear receptor-coactivator interactions

被引:781
作者
Darimont, BD
Wagner, RL
Apriletti, JW
Stallcup, MR
Kushner, PJ
Baxter, JD
Fletterick, RJ
Yamamoto, KR [1 ]
机构
[1] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA
[5] Univ So Calif, Dept Pathol, Los Angeles, CA 90033 USA
关键词
nuclear receptors; coactivators; GRIP1; specificity; interaction site;
D O I
10.1101/gad.12.21.3343
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Combinatorial regulation of transcription implies flexible yet precise assembly of multiprotein regulatory complexes in response to signals. Biochemical and crystallographic analyses revealed that hormone binding leads to the formation of a hydrophobic groove within the ligand binding domain (LBD) of the thyroid hormone receptor that interacts with an LxxLL motif-containing alpha-helix from GRIP1, a coactivator. Residues immediately adjacent to the motif modulate the affinity of the interaction; the motif and the adjacent sequences are employed to different extents in binding to different receptors. Such interactions of amphipathic alpha-helices with hydrophobic grooves define protein interfaces in other regulatory complexes as well. We suggest that these common structural elements impart flexibility to combinatorial regulation, whereas side chains at the interface impart specificity.
引用
收藏
页码:3343 / 3356
页数:14
相关论文
共 53 条
[1]   Cross-validated maximum likelihood enhances crystallographic simulated annealing refinement [J].
Adams, PD ;
Pannu, NS ;
Read, RJ ;
Brunger, AT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5018-5023
[2]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[3]   EXPRESSION OF THE RAT ALPHA-1 THYROID-HORMONE RECEPTOR-LIGAND BINDING DOMAIN IN ESCHERICHIA-COLI AND THE USE OF A LIGAND-INDUCED CONFORMATION CHANGE AS A METHOD FOR ITS PURIFICATION TO HOMOGENEITY [J].
APRILETTI, JW ;
BAXTER, JD ;
LAU, KH ;
WEST, BL .
PROTEIN EXPRESSION AND PURIFICATION, 1995, 6 (03) :363-370
[4]   THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY [J].
BAILEY, S .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 :760-763
[5]   CHARACTERIZATION OF THE LIGAND-DEPENDENT TRANSACTIVATION DOMAIN OF THYROID-HORMONE RECEPTOR [J].
BARETTINO, D ;
RUIZ, MDMV ;
STUNNENBERG, HG .
EMBO JOURNAL, 1994, 13 (13) :3039-3049
[6]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[7]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[8]   Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300 [J].
Chen, HW ;
Lin, RJ ;
Schiltz, RL ;
Chakravarti, D ;
Nash, A ;
Nagy, L ;
Privalsky, ML ;
Nakatani, Y ;
Evans, RM .
CELL, 1997, 90 (03) :569-580
[9]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[10]   A natural transactivation mutation in the thyroid hormone beta receptor: Impaired interaction with putative transcriptional mediators [J].
Collingwood, TN ;
Rajanayagam, O ;
Adams, M ;
Wagner, R ;
Cavailles, V ;
Kalkhoven, E ;
Matthews, C ;
Nystrom, E ;
Stenlof, K ;
Lindstedt, G ;
Tisell, L ;
Fletterick, RJ ;
Parker, MG ;
Chatterjee, VKK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (01) :248-253